GX Lin, CM Chen, MT Zhu, L Zheng - World Neurosurgery, 2022 - Elsevier
Objective Several previous meta-analyses have been published, followed by additional randomized clinical trials investigating the effects of tranexamic acid (TXA) in patients …
AM Mergoum, AS Mergoum, NJ Larson… - Journal of Surgical …, 2024 - Elsevier
Introduction Tranexamic acid (TXA) is a potent antifibrinolytic drug that inhibits the activation of plasmin by plasminogen. While not a new medication, TXA has quickly gained traction …
A Lamy, DA Sirota, F Jacques, A Poostizadeh… - Circulation, 2024 - ahajournals.org
BACKGROUND: Although intravenous tranexamic acid is used in cardiac surgery to reduce bleeding and transfusion, topical tranexamic acid results in lower plasma concentrations …
H Tan, S Pan, C Wei, Z Chen, T Chen - Medicine, 2023 - journals.lww.com
Background: Significant blood loss is still one of the most frequent issues in spinal surgery. There were different hemostatic methods to prevent blood loss during spinal surgery …
S Magni, L Guggenheim, G Fournier, C Parodi… - Journal of Clinical …, 2024 - mdpi.com
Background: Reduction mammaplasty is a common, elective, and safe operation, usually executed in healthy patients. Nonetheless, postoperative complications like bleeding and …
B Gao, Y Liu, Y Yao… - Journal of …, 2024 - Springer
Objectives Perioperative bleeding poses a significant issue during thoracic surgery. Tranexamic acid (TXA) is one of the most commonly used antifibrinolytic agents for surgical …
JH Lee, JY Ryu, JS Lee, KY Choi, HY Chung… - Aesthetic Plastic …, 2022 - Springer
Background Seroma is the most common complication after mastectomy and reconstruction surgery. Therefore, this study aimed to determine whether the topical application of …
J Tonko, K Manoharan, R Amin… - HeartRhythm Case Reports, 2022 - Elsevier
Epicardial connections have been identified as an important cause for failed endocardial atrial fibrillation (AF) ablations. Percutaneous and/or surgical techniques for stand-alone …